Key Takeaways Social media spreads misinformation about ADHD, leading to stigma, underdiagnosis, and inadequate treatment, especially in adults. ADHD involves impaired response inhibition, with diverse presentations often misunderstood, affecting diagnosis and treatment. The Psychiatric Times' Special Report provides evidence-based resources to counter misinformation and promote accurate understanding. Professionals should use evidence-based resources to guide discussions and care, avoiding...

Alkaloid 7-hydroxymitragynine: What is it, and what are the risks? Keypoint: Kratom is an herbal extract that comes from the leaves of a tree in Southeast Asia. Kratom-7 OH is a synthetic form of kratom that is highly potent. Kratom-7 OH has risks similar to opioids. Kratom, a Southeast Asian tree in the coffee family, has become widely available in the United States in various forms for several years now. It is often sold at convenience stores, gas stations, and online. As an addiction...

Early research has linked Alzheimer’s disease (AD) medications cholinesterase inhibitors and N-methyl-D-aspartate (NMDA) receptor antagonists to modest cognitive benefits in children and adolescents with autism spectrum disorder (ASD) and comorbid cognitive disability. The preliminary evidence, which is drawn from a mix of randomized controlled trials (RCTs), cohort studies, case series, and case reports suggests these medications most frequently had a positive effect on learning and memory,...